Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPci-pal Regulatory News (PCIP)

Share Price Information for Pci-pal (PCIP)

Share Price is delayed by 15 minutes
Get Live Data
49.00    0.00 (0.00%)
Bid:
48.00
Ask:
50.00
Spread: 2.00 (4.167%)
Market Cap: £35.50m
PCIP Live PriceLast checked at - London Stock Exchange

Intraday Pci-pal Share Chart

AGM Statement

12 Dec 2023 07:00

RNS Number : 3923W
PCI-PAL PLC
12 December 2023
Ā 

12 December 2023

Ā 

PCI-PAL PLC

("PCI Pal", the "Company" or "the Group")

Ā 

AGM Statement

Ā 

PCI-PAL PLC (AIM: PCIP), the global cloud provider of secure payment solutions for business communications, is pleased to provide the following update ahead of the Company's Annual General Meeting to be held at 11.00 a.m. today.

Ā 

PCI Pal's growth momentum continues in a year where the Company is focused on delivery of another year of strong organic revenue growth whilst also achieving its first full year of adjusted profit. New business sales are ahead of the prior year, with several highlight enterprise customer wins now in deployment phase.Ā 

Ā 

The Company continues to maximise the opportunity presented through its market leading partner eco-system and was therefore pleased to announce its new strategic partnership with Zoom on 13 November 2023. The new partnership will be at launch stage in early 2024 and is already contributing to the Group's sales pipeline.

Ā 

The continued expansion of the Group's partner eco-system and customer base is a reflection of the appeal of PCI Pal's products and services. The year to date has seen continued progress on new product development with a number of new features and products nearing full general availability. This activity has included the Group's first customer sold and live using a new agent desktop user interface which also leverages new payment capabilities provided through the Company's technology partnership with Stripe.

Ā 

The Board is looking forward to the Form of Order hearing concerning its recent resounding victory in its patent lawsuit with a competitor, Sycurio Limited. The hearing will be held on 18 December 2023. PCI Pal has lodged a number of witness statements with the court detailing the reasons why it should be awarded the maximum cost recovery given the strength of its victory in the UK. PCI Pal looks forward to presenting these in court. The Company will issue a further update following the hearing.

Ā 

For further information, please contact:

Ā 

PCI-PAL PLC

Via Walbrook PR

James Barham - Chief Executive Officer

William Good - Chief Financial Officer

Ā 

Cavendish Capital Market Limited (Nominated Adviser and Broker)

+44 (0) 20 7227 0500

Marc Milmo/Simon Hicks/Fergus Sullivan (Corporate Finance)

Sunila De Silva (Corporate Broking)

Ā 

Walbrook PR

+44 (0) 20 7933 8780

Tom Cooper/Paul Vann

+44 (0) 797 122 1972

tom.cooper@walbrookpr.com

Ā 

About PCI Pal:

Ā 

PCI Pal is a leading provider of Software-as-a-Service ("SaaS") solutions that empower companies to take payments from their customers securely, adhere to strict industry governance, and remove their business from the significant risks posed by non-compliance and data loss. Our products secure payments and data in any business communications environment including voice, chat, social, email, and contact centre. We are integrated to, and resold by, some of the worlds' leading business communications vendors, as well as major payment service providers.

Ā 

The entirety of our product-base is available from our global cloud platform hosted in Amazon Web Services ("AWS"), with regional instances across EMEA, North America, and ANZ.

Ā 

For more information visit www.pcipal.com or follow the team on Linkedin: https://www.linkedin.com/company/pci-pal/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
AGMFLFERFSLLLIV
Date   Source Headline
14th Apr 20267:00 amRNS-RHIPAA, HITRUST & SOC 2 Type II certification
18th Mar 20267:00 amRNS-RMajor New Reseller Partnership with Global Telco
10th Mar 20263:07 pmRNSHolding(s) in Company
10th Mar 20263:07 pmRNSHolding(s) in Company
3rd Mar 20267:00 amRNSInterim Results, Analyst Briefing & Investor Pres
23rd Feb 20267:00 amRNS-RNew Major Strategic Reseller Partnership
17th Feb 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
10th Feb 20265:07 pmRNSHolding(s) in Company
6th Feb 202611:26 amRNSHolding(s) in Company
6th Feb 202611:25 amRNSHolding(s) in Company
5th Feb 202612:48 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSTrading Update
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
18th Dec 20254:44 pmRNSGrant of Options under Long-Term Incentive Plan
1st Dec 20252:49 pmRNSResult of AGM
19th Nov 20257:00 amRNS-RStrategic US Healthcare Sector Integration
17th Nov 20253:19 pmRNS-RCMD Presentation Video
14th Nov 20257:00 amRNS-RCMD Presentation & MelloLondon
11th Nov 20257:00 amRNSCapital Markets Day
6th Nov 20254:20 pmRNSAnnual Financial Report & Notice of AGM
25th Sep 20258:45 amRNSHolding(s) in Company
9th Sep 20257:00 amRNSFinal Results, Analyst Briefing & Investor Pres
19th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
30th Jul 20253:18 pmRNSDirector Share Purchases
29th Jul 202510:20 amRNSDirector Share Purchase
29th Jul 20257:01 amRNSTrading & Business Update
29th Jul 20257:00 amRNSNew Product Launch
1st Jul 20257:00 amRNSBoard Changes
20th Jun 202512:00 pmRNSIssue of Equity & TVR
3rd Apr 20259:24 amRNSHolding(s) in Company
12th Mar 20253:20 pmRNSDirector Share Purchases
10th Mar 20257:00 amRNS-RPCI Pal and RingCentral Inc Partnership
6th Mar 20252:00 pmRNSPDMR Issue of Options
4th Mar 20253:49 pmRNSDirector Share Purchase
4th Mar 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
18th Feb 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
27th Jan 20257:00 amRNSTrading Update
11th Dec 20242:42 pmRNSHolding(s) in Company
11th Dec 20242:17 pmRNSResult of AGM
11th Dec 20247:00 amRNSAGM Statement
6th Dec 20244:10 pmRNSExercise of Options & TVR
14th Nov 20244:23 pmRNSAnnual Financial Report & Notice of AGM
22nd Oct 20247:00 amRNSFinal Results, Analyst Briefing & Investor Pres
14th Oct 20247:00 amRNSConfirmation of CFO Appointment
19th Sep 20247:00 amRNSAudit Update & Timing of Results
10th Sep 20244:46 pmRNSHolding(s) in Company
28th Aug 20247:00 amRNSTrading Update, New Partner & Notice of Results
22nd Jul 20249:15 amRNSHolding(s) in Company
1st Jul 20245:23 pmRNSExercise of Options, Director Shareholding & TVR
1st Jul 20247:00 amRNSBoard Changes - Appointment of CFO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.